CYTK
Cytokinetics Inc
64.70$
-1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 285.4% | 378.0% | 361.6% | 566.5% | 1,968.0% | 493.9% | 536.0% | 65.5% | 1,952.3% | 1,236.9% | 471.5% | 161.3% | 94.6% | 161.9% | 56.3% | 675.5% | 283.0% | 320.5% | 173.7% | 227.1% | 254.6% | 4,384.1% | 1,837.2% | 11.5% | |
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -371.5% | -61.3% | 5.4% | -61.9% | 43.7% | -575.5% | -183.0% | -220.5% | -73.7% | -127.1% | -154.6% | -4,284.1% | -1,737.2% | 88.5% | |
| – | 247.6% | 249.4% | 321.5% | 296.7% | 455.2% | 1,574.2% | 391.9% | 434.4% | 48.9% | 1,475.1% | 929.6% | 471.5% | 161.3% | 94.6% | 161.9% | 56.3% | 675.5% | 283.0% | 320.5% | 173.7% | 227.1% | 254.6% | 4,384.1% | 1,837.2% | 461.0% | |
| – | 69.7% | 61.0% | 86.6% | 89.2% | 145.6% | 487.4% | 122.7% | 121.4% | 19.2% | 551.0% | 339.8% | 155.0% | 49.2% | 36.8% | 68.6% | 26.1% | 272.8% | 99.3% | 147.4% | 94.6% | 137.4% | 188.2% | 2,305.6% | 1,165.5% | 322.9% | |
| – | 317.2% | 310.4% | 408.1% | 385.9% | 600.8% | 2,061.6% | 514.7% | 555.8% | 68.0% | 2,026.1% | 1,269.3% | 163.6% | 49.2% | 36.8% | 68.6% | 26.1% | 272.8% | 99.3% | 147.4% | 94.6% | 137.4% | 188.2% | 2,305.6% | 1,165.5% | 783.9% | |
| – | -217.2% | -210.4% | -308.1% | -285.9% | -500.8% | -1,961.6% | -414.7% | -475.7% | 32.0% | -1,926.1% | -1,199.1% | -517.3% | -110.6% | -31.4% | -130.5% | 17.6% | -848.3% | -282.3% | -368.0% | -168.3% | -264.5% | -342.8% | -6,589.7% | -2,902.7% | -695.4% | |
| – | 5.2% | 11.7% | 23.5% | 4.1% | 6.0% | 16.7% | 5.1% | 4.0% | 0.5% | 6.3% | 2.6% | 0.0% | 0.6% | 0.2% | 0.3% | 2.1% | 127.1% | 68.5% | 101.8% | 69.3% | 41.6% | 54.1% | 765.8% | 468.3% | 118.0% | |
| – | – | – | – | -276.7% | -474.1% | -1,826.5% | -358.9% | -453.9% | 30.3% | -1,919.4% | -1,196.5% | -516.1% | -110.0% | -31.2% | -130.9% | 15.5% | -955.9% | -337.4% | -452.9% | -228.0% | -305.7% | -411.2% | -6,988.6% | -3,191.1% | -891.6% | |
| – | 187.5% | -7.9% | 0.9% | – | – | – | – | -1.9% | 0.2% | -6.8% | -5.2% | -9.0% | -1.4% | -1.0% | -2.1% | -0.7% | 5.1% | 13.3% | 101.8% | 66.0% | 38.4% | 14.4% | 155.7% | – | – | |
| – | -187.5% | -202.5% | -309.0% | -276.7% | -474.1% | -1,826.5% | -358.9% | -453.9% | 30.1% | -1,912.6% | -1,196.5% | -551.4% | -110.0% | -31.2% | -130.9% | 15.5% | -955.9% | -337.4% | -452.9% | -228.0% | -305.7% | -411.2% | -6,988.6% | -3,191.1% | -891.6% | |
| – | -217.2% | -185.4% | -278.0% | -248.4% | -434.0% | -1,715.9% | -333.0% | -430.2% | 33.3% | -1,852.3% | -1,163.1% | -526.2% | -109.2% | -30.4% | -128.5% | 18.3% | -814.6% | -265.0% | -346.3% | -155.4% | -250.4% | -348.2% | -6,064.9% | -2,671.2% | -880.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.